Half-life
Estimated 2–4 hours based on preclinical data
Mechanism of Action
Inhibits Nicotinamide N-methyltransferase (NNMT), an enzyme involved in energy metabolism regulation, potentially improving adipose tissue function.
Published Research Ranges & Study Context
Studies have administered: Primarily preclinical; human dosing ranges not established in published literature
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
Preclinical mouse studies showed increased energy expenditure and reduced fat mass. Limited human trial data currently published.
Emerging
Early-stage research — limited human data
Side Effects Observed in Research
Not well-characterized in human research; preclinical data shows favorable safety profile
Available Configurations (SKU Reference)
5AM
50AM
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on 5-Amino-1MQ — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.